Cancer immunotherapy research and drug development holds the promise of bringing new and more effective therapeutics to patients but with this promise come a number of challenges that require new tools and technologies.

Immune checkpoint blockade marked a significant breakthrough in cancer immunotherapies, however, the majority of patients fail to achieve a lasting response, underscoring the necessity to better understand tumor immunity and for alternative strategies that supplement or augment checkpoint blockade.
In this eBook, we describe the application of novel technologies early in drug discovery to explore these alternative strategies to inform on downstream translational investigations.
In addition to providing insights into promising new technologies, tools, and trends, we have also included five protocol examples that have been developed specifically for evaluating immuno-oncology therapies.
Your privacy is important to us.
We'll never share your information.
2024-10-15
2023-12-07
landing_page
Integrated Solutions - In Vitro - I/O Targets/Combinations